IELCART

Initiative for Early Lung Cancer Research on Treatment (IELCART)

Objective

The Initiative for Early Lung Cancer Research for Treatment (IELCART) has its broad research objective the advancement of knowledge about optimal for treatment of clinical Stage I lung cancer. Our overall goal is to reduce rates of lung cancer deaths by early detection and diagnosis of small, early stage lung cancers followed by optimal treatment. 

Eligibility

All patients with a first primary clinical Stage I (N0M0) lung cancer who will undergo surgical, SBRT, watchful waiting or any other treatment will be enrolled prior to treatment at each participating institution.